Medline ® Abstract for Reference 3
of 'Toxicities associated with checkpoint inhibitor immunotherapy'
3
TI
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
AU
Weber JS, Hodi FS, Wolchok JD, et al
SO
J Clin Oncol. 2016;
AD